Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.5.2839

Effects of MicroRNA-106 on Proliferation of Gastric Cancer Cell through Regulating p21 and E2F5  

Yao, Yong-Liang (Kunshan First People's Hospital, Affiliated to Jiangsu University)
Wu, Xiao-Yang (Kunshan First People's Hospital, Affiliated to Jiangsu University)
Wu, Jian-Hong (Kunshan First People's Hospital, Affiliated to Jiangsu University)
Gu, Tao (Kunshan First People's Hospital, Affiliated to Jiangsu University)
Chen, Ling (Kunshan First People's Hospital, Affiliated to Jiangsu University)
Gu, Jin-Hua (Kunshan First People's Hospital, Affiliated to Jiangsu University)
Liu, Yun (Kunshan First People's Hospital, Affiliated to Jiangsu University)
Zhang, Qing-Hui (Kunshan First People's Hospital, Affiliated to Jiangsu University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.5, 2013 , pp. 2839-2843 More about this Journal
Abstract
Objective: To investigate the effects of miR-106b on malignant characteristics of gastric cancer cells, and explore possible mechanisms. Methods: Expression of miR-106b, p21 and E2F was determined by real-time PCR. Transfection with miR-106b mimics was conducted, and gastric cancer cells with miR-106b overexpression were obtained. Cells transfected with mimic mutants and those without transfection served as negative and blank controls, respectively. Flow cytometry and transwell assays were adopted to detect the effects of miR-106b overexpression on cell cycle, migration and invasion of gastric cancer cells. Results:. The expression of miR- 106b in gastric cancer cells was significantly higher than that in normal gastric mucosa cells. Furthermore, the expression level of miR-106b rose according to the degree of malignacy among the three GC cell strains (MKN- 45 > SGC-7901 > MKN-28). Overexpression of miR-106b shortened the G0/G1 phase and accelerated cell cycle progression, while reducing p21 and E2F5, without any significant effects on the capacity for migration and invasion of gastric cancer cells. Conclusions: miR-106b may promote cell cycling of gastric cancer cells through regulation of p21 and E2F5 target gene expression.
Keywords
Gastric cancer; microRNA; proliferation; cell cycle; migration; invasion;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Anglicheau D, Muthukumar T, Suthanthiran M (2010). MicroRNA: small RNAs with big effects. Transplatation, 90, 105-12.
2 Carlsbecker A, Lee JY, Roberts CJ, et al (2010). Cell signalling by microRNA165/6 directs gene dose-dependent root cell fate. Nature, 465, 316-21.   DOI   ScienceOn
3 Calin GA, Sevignani C, Dumitru CD, et al (2001). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Pro Natl Acad Sci USA, 101, 2999-3001.
4 Chen CF, Ridzon DA, Broomer AJ (2005). Real- time quantification of microRNAs by stem-loop RT- PCR. Nucleic Acids Res, 33, e179.   DOI   ScienceOn
5 Chu AS, Friedman JR (2008). A role for microRNA in cystic liver and kidney diseases. J Clin Invest, 118, 3585-7.   DOI   ScienceOn
6 Ferdin J, Kunej T, Calin GA (2010). Non-coding RNAs: Identification of Cancer-Associated microRNAs by Gene Profiling. Technol Cancer Res Treat, 9, 123-38.   DOI
7 Gong H, Liu CM, Liu DP, et al (2005). The role of small RNAs in human diseases: potential troublemaker and therapeutic tools. Med Res Rev, 25, 361-81.   DOI   ScienceOn
8 Herranz H, Cohen SM (2010). MicroRNAs and gene regulatory networks: managing the impact of noise in biological systems. Genes Dev, 24, 1339-44.   DOI   ScienceOn
9 Kahlert C, Kalluri R (2013). Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med, 91, 431-7.   DOI
10 Konishi H, Ichikawa D, Komatsu S, et al (2012). Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer, 106, 740-7.   DOI   ScienceOn
11 Li B, Shi XB, Nori D, et al (2011). Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate, 71, 567-74.   DOI   ScienceOn
12 Li SC, Liao YL, Ho MR, et al (2012). miRNA arm selection and isomiR distribution in gastric cancer. BMC Genomics, 13, S13.
13 Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using Real-Time quantitative PCR and the 2-rrCt method. Methods, 25, 402-8.   DOI   ScienceOn
14 Manikandan J, Aarthi JJ, Kumar SD, et al (2008). Oncomirs: The potential role of non-coding microRNAs in understanding cancer. Bioinformation, 2, 330-4.   DOI
15 Martin L, Chang HY (2012). Uncovering the role of genomic “dark matter” in human disease. J Clin Invest, 122, 1589-95.   DOI   ScienceOn
16 Zeng Y, Wagner EJ, Cullen BR (2002). Both natural and designed microRNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell, 9, 1327-33.   DOI   ScienceOn
17 Moss EG (2002). MicroRNAs: hidden in the genome. Curr Biol, 12, 138-40.   DOI   ScienceOn
18 Trompeter HI, Abbad H, Iwaniuk KM, et al (2011). MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS One, 6, e16138.   DOI   ScienceOn
19 Xu L, Dai WQ, Xu XF, et al (2012). Effects of multiple-target anti-microRNA antisense oligodeoxyribonucleotides on proliferation and migration of gastric cancer cells. Asian Pac J Cancer Prev, 13, 3203-7.   DOI   ScienceOn
20 Zhang Y, Liu D, Chen X, et al (2010). Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell, 39, 133-44.   DOI   ScienceOn